{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:23:00Z","timestamp":1790572980523,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10096-020-04020-5","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T06:03:08Z","timestamp":1598853788000},"page":"159-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacological inhibition of poly (ADP-ribose) polymerase by olaparib ameliorates influenza-virus-induced pneumonia in mice"],"prefix":"10.1007","volume":"40","author":[{"given":"Wei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"issue":"7195","key":"4020_CR1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nature06945","volume":"453","author":"A Rambaut","year":"2008","unstructured":"Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, Holmes EC (2008) The genomic and epidemiological dynamics of human influenza A virus. Nature 453(7195):615\u2013U612","journal-title":"Nature"},{"issue":"7559","key":"4020_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature14460","volume":"523","author":"T Bedford","year":"2015","unstructured":"Bedford T, Riley S, Barr IG, Broor S, Chadha M, Cox NJ, Daniels RS, Gunasekaran CP, Hurt AC, Kelso A, Klimov A, Lewis NS, Li XY, McCauley JW, Odagiri T, Potdar V, Rambaut A, Shu YL, Skepner E, Smith DJ, Suchard MA, Tashiro M, Wang DY, Xu XY, Lemey P, Russell CA (2015) Global circulation patterns of seasonal influenza viruses vary with antigenic drift. Nature 523(7559):217\u2013U206","journal-title":"Nature"},{"issue":"1","key":"4020_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/irv.12491","volume":"12","author":"N Chaiyakunapruk","year":"2018","unstructured":"Chaiyakunapruk N, Kotirum S, Newall AT, Lambach P, Hutubessy RCW (2018) Rationale and opportunities in estimating the economic burden of seasonal influenza across countries using a standardized WHO tool and manual. Influenza Other Respir Viruses 12(1):13\u201321","journal-title":"Influenza Other Respir Viruses"},{"issue":"8","key":"4020_CR4","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","volume":"16","author":"EA Belongia","year":"2016","unstructured":"Belongia EA, Simpson MD, King JP, Sundaram ME, Kelley NS, Osterholm MT, McLean HQ (2016) Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis 16(8):942\u2013951","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"4020_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.yexcr.2014.07.003","volume":"329","author":"C Beck","year":"2014","unstructured":"Beck C, Robert I, Reina-San-Martin B, Schreiber V, Dantzer F (2014) Poly (ADP-ribose) polymerases in double-strand break repair: focus on PARP1, PARP2 and PARP3. Exp Cell Res 329(1):18\u201325","journal-title":"Exp Cell Res"},{"issue":"6","key":"4020_CR6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/0300-9084(96)88161-2","volume":"77","author":"M Masutani","year":"1995","unstructured":"Masutani M, Nozaki T, Wakabayashi K, Sugimura T (1995) Role of poly (ADP-ribose) polymerase in cell-cycle checkpoint mechanisms following gamma-irradiation. Biochimie 77(6):462\u2013465","journal-title":"Biochimie"},{"issue":"9","key":"4020_CR7","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1007\/s00018-002-8527-2","volume":"59","author":"PO Hassa","year":"2002","unstructured":"Hassa PO, Hottiger MO (2002) The functional role of poly (ADP-ribose) polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cell Mol Life Sci 59(9):1534\u20131553","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"4020_CR8","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/ajrccm.165.3.2106050","volume":"165","author":"L Liaudet","year":"2002","unstructured":"Liaudet L, Pacher P, Mabley JG, Virag L, Soriano FG, Hasko G, Szabo C (2002) Activation of poly(ADP-ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med 165(3):372\u2013377","journal-title":"Am J Respir Crit Care Med"},{"key":"4020_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bcp.2018.01.027","volume":"150","author":"V Dharwal","year":"2018","unstructured":"Dharwal V, Naura AS (2018) PARP-1 inhibition ameliorates elastase induced lung inflammation and emphysema in mice. Biochem Pharmacol 150:24\u201334","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"4020_CR10","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.1167\/iovs.09-3752","volume":"50","author":"M Michaelis","year":"2009","unstructured":"Michaelis M, Geiler J, Klassert D, Doerr HW, Cinatl J Jr (2009) Infection of human retinal pigment epithelial cells with influenza A viruses. Invest Ophthalmol Vis Sci 50(11):5419\u20135425","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"4020_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jpha.2019.09.005","volume":"10","author":"X Liang","year":"2020","unstructured":"Liang X, Huang Y, Pan X, Hao Y, Chen X, Jiang H, Li J, Zhou B, Yang Z (2020) Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-kappaB and p38 MAPK pathway. J Pharm Anal 10(2):130\u2013146","journal-title":"J Pharm Anal"},{"issue":"1\u20132","key":"4020_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11010-014-2271-4","volume":"400","author":"K Kapoor","year":"2015","unstructured":"Kapoor K, Singla E, Sahu B, Naura AS (2015) PARP inhibitor, olaparib ameliorates acute lung and kidney injury upon intratracheal administration of LPS in mice. Mol Cell Biochem 400(1\u20132):153\u2013162","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"4020_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/jmv.25330","volume":"91","author":"K Hatayama","year":"2019","unstructured":"Hatayama K, Nosaka N, Yamada M, Yashiro M, Fujii Y, Tsukahara H, Liu K, Nishibori M, Matsukawa A, Morishima T (2019) Combined effect of anti-high-mobility group box-1 monoclonal antibody and peramivir against influenza A virus-induced pneumonia in mice. J Med Virol 91(3):361\u2013369","journal-title":"J Med Virol"},{"issue":"11","key":"4020_CR14","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1172\/JCI0215849","volume":"110","author":"JA Belperio","year":"2002","unstructured":"Belperio JA, Keane MP, Burdick MD, Londhe V, Xue YY, Li K, Phillips RJ, Strieter RM (2002) Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest 110(11):1703\u20131716","journal-title":"J Clin Invest"},{"issue":"1","key":"4020_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/CCM.0b013e3182676352","volume":"41","author":"M Yashiro","year":"2013","unstructured":"Yashiro M, Tsukahara H, Matsukawa A, Yamada M, Fujii Y, Nagaoka Y, Tsuge M, Yamashita N, Ito T, Yamada M, Masutani H, Yodoi J, Morishima T (2013) Redox-active protein thioredoxin-1 administration ameliorates influenza A virus (H1N1)-induced acute lung injury in mice. Crit Care Med 41(1):171\u2013181","journal-title":"Crit Care Med"},{"issue":"7","key":"4020_CR16","doi-asserted-by":"publisher","first-page":"e67976","DOI":"10.1371\/journal.pone.0067976","volume":"8","author":"B Pulli","year":"2013","unstructured":"Pulli B, Ali M, Forghani R, Schob S, Hsieh KL, Wojtkiewicz G, Linnoila JJ, Chen JW (2013) Measuring myeloperoxidase activity in biological samples. PLoS One 8(7):e67976","journal-title":"PLoS One"},{"issue":"1","key":"4020_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.intimp.2011.12.007","volume":"12","author":"YC Li","year":"2012","unstructured":"Li YC, Peng SZ, Chen HM, Zhang FX, Xu PP, Xie JH, He JJ, Chen JN, Lai XP, Su ZR (2012) Oral administration of patchouli alcohol isolated from Pogostemonis Herba augments protection against influenza viral infection in mice. Int Immunopharmacol 12(1):294\u2013301","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"4020_CR18","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.tim.2018.05.013","volume":"26","author":"EC Hutchinson","year":"2018","unstructured":"Hutchinson EC (2018) Influenza Virus. Trends Microbiol 26(9):809\u2013810","journal-title":"Trends Microbiol"},{"key":"4020_CR19","doi-asserted-by":"publisher","first-page":"197731","DOI":"10.1016\/j.virusres.2019.197731","volume":"272","author":"JA Vazquez-Perez","year":"2019","unstructured":"Vazquez-Perez JA, De La Rosa-Zamboni D, Vega-Sanchez AE, Gutierrez-Gonzalez LH, Tellez-Navarrete NA, Campos F, Guadarrama-Perez C, Sandoval JL, Castillejos-Lopez M, Jimenez-Juarez RN, Sanchez-Huerta JL, Perez-Mendez BB, Perez-Padilla R (2019) Amino acid changes in HA and determinants of pathogenicity associated with influenza virus A H1N1pdm09 during the winter seasons 2015-2016 and 2016-2017 in Mexico. Virus Res 272:197731","journal-title":"Virus Res"},{"key":"4020_CR20","doi-asserted-by":"crossref","unstructured":"Destras G, Pichon M, Simon B, Valette M, Escuret V, Bolze PA, Dubernard G, Gaucherand P, Lina B, Josset L (2019) Impact of pregnancy on intra-host genetic diversity of influenza A viruses in hospitalised women: a retrospective cohort study. J Clin Med 8(11):1974","DOI":"10.3390\/jcm8111974"},{"key":"4020_CR21","doi-asserted-by":"publisher","unstructured":"Veiga A, Martins LG, Riediger I, Mazetto A, Debur MDC, Gregianini TS (2020) More than just a common cold: endemic coronaviruses OC43, HKU1, NL63, and 229E associated with severe acute respiratory infection and fatality cases among healthy adults. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.26362","DOI":"10.1002\/jmv.26362"},{"issue":"38","key":"4020_CR22","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.2174\/0929867324666170920165926","volume":"25","author":"J Han","year":"2018","unstructured":"Han J, Perez J, Schafer A, Cheng H, Peet N, Rong L, Manicassamy B (2018) Influenza virus: small molecule therapeutics and mechanisms of antiviral resistance. Curr Med Chem 25(38):5115\u20135127","journal-title":"Curr Med Chem"},{"issue":"12","key":"4020_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrclinonc.2017.161","volume":"14","author":"D Killock","year":"2017","unstructured":"Killock D (2017) Targeted therapy: ARIEL3 - broad benefit of PARP inhibitors in ovarian cancer. Nat Rev Clin Oncol 14(12):713","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"4020_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.coph.2008.06.016","volume":"8","author":"CJ Lord","year":"2008","unstructured":"Lord CJ, Ashworth A (2008) Targeted therapy for cancer using PARP inhibitors. Curr Opin Pharmacol 8(4):363\u2013369","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"4020_CR25","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ajpath.2010.12.004","volume":"178","author":"XQ Ba","year":"2011","unstructured":"Ba XQ, Garg NJ (2011) Signaling mechanism of poly (ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases. Am J Pathol 178(3):946\u2013955","journal-title":"Am J Pathol"},{"issue":"4","key":"4020_CR26","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/imm.12099","volume":"139","author":"MM Rosado","year":"2013","unstructured":"Rosado MM, Bennici E, Novelli F, Pioli C (2013) Beyond DNA repair, the immunological role of PARP-1 and its siblings. Immunology 139(4):428\u2013437","journal-title":"Immunology"},{"key":"4020_CR27","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3389\/fimmu.2017.01172","volume":"8","author":"GS Sethi","year":"2017","unstructured":"Sethi GS, Dharwal V, Naura AS (2017) Poly (ADP-ribose) polymerase-1 in lung inflammatory disorders: a review. Front Immunol 8:1172","journal-title":"Front Immunol"},{"issue":"3","key":"4020_CR28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1165\/rcmb.2001-0015OC","volume":"28","author":"AH Boulares","year":"2003","unstructured":"Boulares AH, Zoltoski AJ, Sherif ZA, Jolly P, Massaro D, Smulson ME (2003) Gene knockout or pharmacological inhibition of poly (ADP-ribose) polymerase-1 prevents lung inflammation in a murine model of asthma. Am J Resp Cell Mol 28(3):322\u2013329","journal-title":"Am J Resp Cell Mol"},{"issue":"3","key":"4020_CR29","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1124\/jpet.104.072546","volume":"311","author":"Y Suzuki","year":"2004","unstructured":"Suzuki Y, Masini E, Mazzocca C, Cuzzocrea S, Ciampa A, Suzuki H, Bani D (2004) Inhibition of poly (ADP-ribose) polymerase prevents allergen-induced asthma-like reaction in sensitized Guinea pigs. J Pharmacol Exp Ther 311(3):1241\u20131248","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"4020_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.humimm.2012.02.002","volume":"73","author":"L Liu","year":"2012","unstructured":"Liu L, Ke Y, Jiang X, He F, Pan L, Xu L, Zeng X, Ba X (2012) Lipopolysaccharide activates ERK-PARP-1-RelA pathway and promotes nuclear factor-kappaB transcription in murine macrophages. Hum Immunol 73(5):439\u2013447","journal-title":"Hum Immunol"},{"issue":"2","key":"4020_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/01.anes.0000299434.86640.15","volume":"108","author":"R Vaschetto","year":"2008","unstructured":"Vaschetto R, Kuiper JW, Chiang SR, Haitsma JJ, Juco JW, Uhlig S, Plotz FB, Della Corte F, Zhang H, Slutsky AS (2008) Inhibition of poly (adenosine diphosphate-ribose) polymerase attenuates ventilator-induced lung injury. Anesthesiology 108(2):261\u2013268","journal-title":"Anesthesiology"},{"issue":"6","key":"4020_CR32","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1189\/jlb.0309183","volume":"86","author":"M Zerfaoui","year":"2009","unstructured":"Zerfaoui M, Naura AS, Errami Y, Hans CP, Rezk BM, Park J, Elsegeiny W, Kim H, Lord K, Kim JG, Boulares AH (2009) Effects of PARP-1 deficiency on airway inflammatory cell recruitment in response to LPS or TNF: differential effects on CXCR2 ligands and Duffy antigen receptor for chemokines. J Leukoc Biol 86(6):1385\u20131392","journal-title":"J Leukoc Biol"},{"issue":"11","key":"4020_CR33","doi-asserted-by":"publisher","first-page":"e79757","DOI":"10.1371\/journal.pone.0079757","volume":"8","author":"G Wang","year":"2013","unstructured":"Wang G, Huang X, Li Y, Guo K, Ning P, Zhang Y (2013) PARP-1 inhibitor, DPQ, attenuates LPS-induced acute lung injury through inhibiting NF-kappaB-mediated inflammatory response. PLoS One 8(11):e79757","journal-title":"PLoS One"},{"key":"4020_CR34","doi-asserted-by":"crossref","unstructured":"Si MKH, Mitaka C, Tulafu M, Abe S, Kitagawa M, Ikeda S, Eishi Y, Kurata S, Tomita M (2013) Inhibition of poly (adenosine diphosphate-ribose) polymerase attenuates lung-kidney crosstalk induced by intratracheal lipopolysaccharide instillation in rats. Respir Res 14:126","DOI":"10.1186\/1465-9921-14-126"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04020-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-020-04020-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04020-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T23:41:27Z","timestamp":1630366887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-020-04020-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4020"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-04020-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]},"assertion":[{"value":"1 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the animal-involved experiments were performed in accordance with the Animal Care and Use Committee of Cangzhou Central Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}